Gene therapy play RegenxBio raises $30M

RegenxBio Inc. (Washington, D.C.) raised $30 million in an untranched series C round led by new investors Venrock

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE